WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
A bill that would end an underhanded tactic that delays the introduction of generic drugs in the marketplace is pending in the Senate.
The tactic, known as “pay for delay,” occurs when a brand-name drug maker pays a significant sum of money to a generic drug maker in exchange for delaying the marketing of the new generic drug.